# Aldebaran Therapeutics, Inc. — Form D

Aldebaran Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-28. The offering totals $1.2M, of which $800K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-03-28
- Form: D
- Accession: 0001918979-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $800K
- Remaining: $400K
- Investors: 20
- Date of first sale: 2022-02-09
- Revenue range: Decline to Disclose
- SEC file number: 021-439130

## Issuer

- Name: Aldebaran Therapeutics, Inc.
- CIK: 0001918979
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 275 SECOND AVE, WALTHAM, MA, 02451
- Phone: 617-203-7118

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Carlos Loya | Director | Waltham, MA |
| Lauren Mifflin | Director | Waltham, MA |
| Chris Pacheco | Director | Waltham, MA |
| Carlos Loya | Executive Officer | Waltham, MA |

## More

- [CIK 1918979 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1918979&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001918979-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.